Education and Training
Study of Dextromethorphan in OCD and Related Disorders
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Fluoxetine
- drug: Dextromethorphan
Eligibility
Inclusion Criteria:
- Diagnosis of obsessive-compulsive disorder (OCD), body dysmorphic disorder (BDD),
illness anxiety disorder (IAD) or somatic symptom disorder (SSD)
- Living within California
- Capacity to provide informed consent
Exclusion Criteria:
- Current bipolar disorder or psychotic disorder
- Active moderate or severe substance use disorder, lifetime severe substance use
disorder
- Pregnant or nursing women
- Use of prescribed psychotropic medications other than fluoxetine for 2 weeks prior to
study start
- Having commenced OCD-targeted exposure and response-prevention (ExRP) psychotherapy
within 2 months of study start
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pavithra Makunda, MS
650-723-4095
I'm interested